WESPAC Advisors SoCal’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-51,880
Closed -$3.26M 102
2023
Q3
$3.26M Buy
51,880
+330
+0.6% +$20.6K 1.1% 34
2023
Q2
$2.91M Sell
51,550
-190
-0.4% -$10.5K 1% 34
2023
Q1
$3M Buy
51,740
+180
+0.3% +$12.1K 1.03% 34
2022
Q4
$3.73M Buy
+51,560
New +$3.69M 1.39% 28
2017
Q1
Sell
-356
Closed -$17.1K 256
2016
Q4
$17.1K Buy
356
+3
+0.8% +$138 0.01% 160
2016
Q3
$14K Sell
353
-1,518
-81% -$57.1K 0.01% 171
2016
Q2
$66.4K Buy
1,871
+17
+0.9% +$663 0.04% 110
2016
Q1
$72.6K Buy
+1,854
New +$69.3K 0.05% 103

Other funds holding MET

WESPAC Advisors SoCal's MET Position: Q4 2023 in Review

WESPAC Advisors SoCal sold out of MetLife (MET) in Q4 2023, closing a stake of 51,880 shares — an estimated $3.26M sold.

WESPAC Advisors SoCal first reported a position in MET in Q1 2016 and held it in 8 quarters. The position peaked at $3.73M in Q4 2022. 1,262 funds tracked by Wall St. Rank hold MET as of Q4 2023.

  • WESPAC Advisors SoCal reported no remaining MetLife position as of Q4 2023 after selling out during the quarter.
  • WESPAC Advisors SoCal sold 51,880 MetLife shares in Q4 2023, an estimated $3.26M.
  • WESPAC Advisors SoCal first reported a position in MetLife in Q1 2016 and held it in 8 quarters.
  • WESPAC Advisors SoCal's MetLife position peaked at $3.73M in Q4 2022.
  • 1,262 funds tracked by Wall St. Rank held MetLife as of Q4 2023.

Based on WESPAC Advisors SoCal's 13F filing for Q4 2023, filed 25 Jan 2024.